WallStSmart

Nextracker Inc. Class A Common Stock (NXT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nextracker Inc. Class A Common Stock generates 1292% more annual revenue ($3.60B vs $258.90M). NXT leads profitability with a 16.4% profit margin vs -15.5%. NXT earns a higher WallStSmart Score of 62/100 (C+).

NXT

Buy

62

out of 100

Grade: C+

Growth: 8.7Profit: 8.5Value: 4.0Quality: 6.3
Piotroski: 4/9Altman Z: 1.51

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NXTOvervalued (-6.7%)

Margin of Safety

-6.7%

Fair Value

$112.36

Current Price

$114.27

$1.91 premium

UndervaluedFair: $112.36Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NXT2 strengths · Avg: 10.0/10
Return on EquityProfitability
33.2%10/10

Every $100 of equity generates 33 in profit

Revenue GrowthGrowth
33.9%10/10

Revenue surging 33.9% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

NXT3 concerns · Avg: 3.3/10
P/E RatioValuation
29.1x4/10

Moderate valuation

Altman Z-ScoreHealth
1.514/10

Distress zone — elevated risk

PEG RatioValuation
3.042/10

Expensive relative to growth rate

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : NXT

The strongest argument for NXT centers on Return on Equity, Revenue Growth. Profitability is solid with margins at 16.4% and operating margin at 19.4%. Revenue growth of 33.9% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : NXT

The primary concerns for NXT are P/E Ratio, Altman Z-Score, PEG Ratio.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

NXT profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

NXT carries more volatility with a beta of 2.02 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOLAR industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NXT scores higher overall (62/100 vs 41/100), backed by strong 16.4% margins and 33.9% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nextracker Inc. Class A Common Stock

TECHNOLOGY · SOLAR · USA

Nextracker Inc., an energy solutions company, provides solar tracker solutions for PV projects. The company is headquartered in Fremont, California.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?